Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

Analysts' ratings for Elevance Health ELV over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates the ...

Elevance Health shares fell 21% in 2024 due to weak fundamental performance, with revenue growing low-single-digits and flat earnings per share. The company is expanding its non-insurance ...

Analysts use this formula to calculate it for Elevance Health: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.13 = US$10b ÷ (US$ ...

Unless the payments are sustainable, the dividend yield doesn't mean too much. Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large ...

As you can see from the chart above the percentage of shares that are sold short for Elevance Health has grown since its last report. This does not mean that the stock is going to fall in the near ...

INDIANAPOLIS — INDIANAPOLIS — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1.81 per share.

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...